AKOS B029384
|
- $215 - $1020
- Product name: AKOS B029384
- CAS: 1006320-00-8
- MF: C4H3ClF2N2O2S
- MW: 216.59
- EINECS:
- MDL Number:MFCD08558182
- Synonyms:AKOS B029384;1-(difluoromethyl)-4-pyrazolesulfonyl chloride;1-(difluoromethyl)pyrazole-4-sulfonyl chloride;1-Difluoromethyl-1H-pyrazole-4-sulfonyl chloride;1H-Pyrazole-4-sulfonyl chloride, 1-(difluoromethyl)-;1-(difuoromethyl)pyrazole-4-sulfonyl chloride
4 prices
Selected condition：
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1G
- 5g
- ManufacturerAK Scientific
- Product number7210AC
- Product description1-Difluoromethyl-1H-pyrazole-4-sulfonylchloride
- Packaging500mg
- Price$340
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0039149
- Product description1-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-SULFONYL CHLORIDE 95.00%
- Packaging1G
- Price$651
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11369026
- Product description1-(Difluoromethyl)-1H-pyrazole-4-sulfonylchloride 95+%
- Packaging5g
- Price$752
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number034537
- Product description1-Difluoromethyl-1H-pyrazole-4-sulfonyl chloride
- Packaging500mg
- Price$215
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 7210AC | 1-Difluoromethyl-1H-pyrazole-4-sulfonylchloride | 500mg | $340 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | HCH0039149 | 1-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-SULFONYL CHLORIDE 95.00% | 1G | $651 | 2021-12-16 | Buy |
| Crysdot | CD11369026 | 1-(Difluoromethyl)-1H-pyrazole-4-sulfonylchloride 95+% | 5g | $752 | 2021-12-16 | Buy |
| Matrix Scientific | 034537 | 1-Difluoromethyl-1H-pyrazole-4-sulfonyl chloride | 500mg | $215 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|